Wockhardt Q4 Net Loss Shrinks to Rs 45 cr
x
Wockhardt reports reduced net loss of Rs 45 crore in Q4 FY25, compared to Rs 177 crore in Q4 FY24. Revenue increased to Rs 743 crore. FY25 net loss at Rs 57 crore.
New Delhi, May 29 (PTI) Drug firm Wockhardt on Thursday reported a consolidated net loss of Rs 45 crore in the fourth quarter ended March 31, 2025.
The drug maker had reported a net loss of Rs 177 crore in the January-March quarter of FY24.
Revenue from operations rose to Rs 743 crore in the fourth quarter as compared to Rs 700 crore in the year-ago period, Wockhardt said in a regulatory filing.
For FY25, the company said its net loss stood at Rs 57 crore as compared to Rs 472 crore in the year-ago period.
Revenue increased to Rs 3,012 crore as compared to Rs 2,798 crore in 2023-24 fiscal.
Shares of the company closed at Rs 1,347.75 apiece, 0.63 per cent higher from previous close, on the BSE.
The drug maker had reported a net loss of Rs 177 crore in the January-March quarter of FY24.
Revenue from operations rose to Rs 743 crore in the fourth quarter as compared to Rs 700 crore in the year-ago period, Wockhardt said in a regulatory filing.
For FY25, the company said its net loss stood at Rs 57 crore as compared to Rs 472 crore in the year-ago period.
Revenue increased to Rs 3,012 crore as compared to Rs 2,798 crore in 2023-24 fiscal.
Shares of the company closed at Rs 1,347.75 apiece, 0.63 per cent higher from previous close, on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- PC Jeweller L
- 16.71 (+ 19.10)
- 58630412
- Vodafone Idea L
- 7.36 ( -1.74)
- 51743860
- Quasar India Ltd.
- 0.47 (+ 4.44)
- 34986989
- Sunshine Capital
- 0.29 ( -3.33)
- 30434905
- Khoobsurat
- 0.73 (+ 4.29)
- 24059472
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback